Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory AITL
Clinical trial NCT03593018 · COMPLETED
Trial details
- NCT number
- NCT03593018
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-09
- Primary completion
- 2021-02-10
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.